-
Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R01 Clinical Trial Optional)
(PAR-23-319)
John E. Fogarty International Center
National Institute on Aging
National Cancer Institute
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Disease Prevention
Application Receipt Date(s): March 11, 2024
-
Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed)
(PAR-24-055)
National Institute of General Medical Sciences
Application Receipt Date(s): Not Applicable
-
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
(PAR-24-072)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
(PAR-24-082)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): March 13, 2024
-
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
(PAR-24-085)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)
(PAR-24-088)
National Institute of Mental Health
National Institute on Aging
National Institute on Drug Abuse
National Eye Institute
Application Receipt Date(s): January 7, 2027
-
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
(PAR-24-091)
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
Application Receipt Date(s): Multiple dates, see announcement.
-
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
(PAR-24-092)
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
Application Receipt Date(s): Multiple dates, see announcement.
-
Centers of Excellence for Translational Research (CETR) (U19 Clinical Trial Not Allowed)
(RFA-AI-23-065)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): April 29, 2024
-
Bat Immunology Network Research Projects (R01 Clinical Trial Not Allowed)
(RFA-AI-23-068)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): May 24, 2024
-
Bat Immunology Network Research Resource Program (U24 Clinical Trial Not Allowed)
(RFA-AI-23-069)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): May 24, 2024
-
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
(RFA-CA-24-016)
National Cancer Institute
Application Receipt Date(s): November 15, 2024
-
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
(RFA-CA-24-017)
National Cancer Institute
Application Receipt Date(s): November 15, 2024
-
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
(RFA-CA-24-018)
National Cancer Institute
Application Receipt Date(s): November 15, 2024
-
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
(RFA-CA-24-019)
National Cancer Institute
Application Receipt Date(s): November 15, 2024
-
FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
(RFA-FD-24-022)
Food and Drug Administration
Application Receipt Date(s): February 29, 2024